1 Suva LJ,Washam C,Nicholas RW,et al.Bone metastasis:mechanisms and therapeutic opportunities[J].Nat Rev Endocrinol,2011,7(4):208-218. 2 Meads MB,Hazlehurst LA,Dalton WS,The bone marrow microenvironment as a tumor sanctuary and contributor to durg resistance[J].Clin Cancer Res,2008,14(9):2519-2526. 3 Kruger TE,Miller AH,Godwin AK,et al.Bone sialoprotein and osteopontin in bone metastasis of osteotropic cancers[J].Crit Rev Oncol Hematol,2014,89(2):330-341. 4 Staines KA,MacRae VE,Farquharson C.The importance of the SIBLING family of proteins on skeletal mineralisation and bone remodelling[J].Endocrinol,2012,214(3):241-255. 5 Bellahcène A,Castronovo V,Ogbureke KU,et al.Small integrin-binding ligand N-linked glycoproteins(SIBLINGs):multifunctional proteins in cancer[J].Nat Rev Cancer,2008,8(3):212-226. 6 Bouleftour W,Bouet G,Granito RN,et al.Blocking the expression of both bone sialoprotein(BSP)and osteopontin(OPN)impairs the anabolic action of PTH in mouse calvaria bone[J].Cell Physiol,2015,30(3):568-577. 7 Khalil A,Elgedawy J,Faramawi MF,et al.Plasma osteopontin level as a diagnostic marker of hepatocellular carcinoma in patients with radiological evidence of focal hepatic lesions[J].Tumori,2013,99(1):100-107. 8 Hou X,Wu X,Huang P,et al.Osteopontin is a useful predictor of bone metastasis and survival in patients with locally advanced nasopharyngeal carcinoma[J].Int J Cancer,2015,137(7):1672-1678. 9 Chen Y,Liu H,Wu W,et al.Osteopontin genetic variants are associated with overall survival in advanced non-small-cell lung cancer patients and bone metastasis[J].Exp Clin Cancer Res,2013,32:45. 10 Hou X,Wu X,Huang P,et al.Osteopontin is a useful predictor of bone metastasis and survival in patients with locally advanced nasopharyngeal carcinoma[J].Int J Cancer,2015,137(7):1672-1678. 11 Ortiz-Martínez F,Sanmartín E,Pomares-Navarro E,et al.Osteopontin regulates VEGFA and ICAM-1 mRNA expression in breast carcinoma[J].Am J Clin Pathol,2015,143(6):812-822. 12 Weber CE,Kothari AN,Wai PY,et al.Osteopontin mediates an MZFi-TGF-betas-dependent transformation of mesenchymal stem cells into cancer-associated fibroblasts in breast cancer[J].Oncogene,2014,34(37):4821-4833. 13 Sfiridaki A,Miyakis S,Pappa C,et al.Circulating osteopontin:a dual marker of bone destruction and angiogenesis in patients with multiple myeloma[J].Hematol Oncol,2011,4:22. 14 Boyerinas B,Zafrir M,Yesilkanal AE,et al.Adhesion to osteopontin in the bone marrow niche regulates lymphoblastic leukemia cell dormancy[J].Blood,2013,121(24):4821-4831. 15 Malaval L,Wade-Guéye NM,Boudiffa M,et al.Bone sialoprotein plays a functional role in bone formation and osteoclastogenesis[J].J Exp Med,2008,205(5):1145-1153. 16 Valverde P,Zhang J,Fix A,et al.Overexpression of bone sialoprotein leads to an uncoupling of bone formation and bone resorption in mice[J].J Bone Miner Res,2008,23(11):1775-1788. 17 Uccello M,Malaguarnera G,Vacante M,et al.Serum bone sialoprotein levels and bone metastases[J].Cancer Res Ther,2011,7(2):115-119. 18 Wang J,Wang L,Xia B,et al.BSP gene silencing inhibits migration,invasion,and bone metastasis of MDA-MB-231BO human breast cancer cells[J].PLoS One,2013,8(5):e62936. 19 Righi L,Bollito E,Ceppi P,et al.Prognostic role of bone sialoprotein in clear cell renal carcinoma[J].Anticancer Res,2013,33(6):2679-2687. 20 Sharp JA,Waltham M,Williams ED,et al.Transfection of MDA-MB-231 human breast carcinoma cells with bone sialoprotein(BSP)stimulates migration and invasion in vitro and growth of primary and secondary tumors in nude mice[J].Clin Exp Metastasis,2004,21(1):19-29. 21 王丽,王捷.BSP沉默基因对乳腺癌细胞的粘附、侵袭和骨转移性质的影响[J].生物工程学报,2011,27(2):233-239. 22 Tu Q,Zhang J,Fix A,et al.Targeted overexpression of BSP in osteoclasts promotes bone metastasis of breast cancer cells[J].J Cell Physiol,2009,218(1):135-145. 23 Reufsteck C,Lifshitz-Shovali R,Zepp M,et al.Silencing of skeletal metastasis-associated genes impairs migration of breast cancer cells and reduces osteolytic bone lesions[J].Clin Exp Metastasis,2012,29(5):441-456. 24 Yamaguchi M,Murata T,Shoji M,et al.The flavonoid p-hydroxycinnamic acid mediates anticancer effects on MDA-MB-231 human breast cancer cells in vitro:Implications for suppression of bone metastases[J].Int J Oncol,2015,47(4):1563-1571. 25 Martini D,Trirè A,Breschi L,et al.Dentin matrix protein 1 and dentin sialophosphoprotein in human sound and carious teeth:an immunohistochemical and colorimetric assay[J].Eur J Histochem,2013,57(4):e32. 26 Lamour V,Nokin MJ,Henry A,et al.SIBLING proteins:molecular tools for tumor progression and angiogenesis[J].Med Sci(Paris),2013,29:1018-1025. 27 Jacob A,Zhang Y,George A.Transcriptional regulation of dentin matrix protein 1(DMP1)in odontoblasts and osteoblasts[J].Connect Tissue Res,2014,55(1):107-112. 28 Schulze J,Albers J,Baranowsky A,et al.Osteolytic prostate cancer cells induce the expression of specific cytokines in bone-forming osteoblasts through a Stat3/5-dependent mechanism[J].Bone,2010,46(2):524-533. 29 Pirotte S,Lamour V,Lambert V,et al.Dentin matrix protein 1 induces membrane expression of VE-cadherin on endothelial cells and inhibits VEGF-induced angiogenesis by blocking VEGFR-2 phosphorylation[J].Blood,2011,117(8):2515-2526. 30 Kapinas K,Lowther KM,Kessler CB,et al.Bone matrix osteonectin limits prostate cancer cell growth and survival[J].Matrix Biol,2012,31(5):299-307. 31 Derosa CA,Furusato B,Shaheduzzaman S,et al.Elevated osteonectin/SPARC expression in primary prostate cancer predicts metastatic progression[J].Prostate Cancer Prostatic Dis,2012,15(2):150-156. 32 Weidle UH,Birzele F,Kollmorgen G,et al,Molecular mechanisms of bone metastasis[J].Cancer Genomics Proteomics,2016,13(1):1-12. 33 Chen N,Ye XC,Chu K,et al.A secreted isoform of ErbB3 promotes osteonectin expression in bone and enhances the invasiveness of prostate cancer cells[J].Cancer Res,2007,67(14):6544-6548. 34 Sethi S,Macoska J,Chen W,et al.Molecular signature of epithelial-mesenchymal transition(EMT)in human prostate cancerbone metastasis[J].Am J Transl Res,2010,3(1):90-99. 35 Koblinski JE,Kaplan-Singer BR,VanOsdol SJ,et al.Endogenous osteonectin/SPARC/BM-40 expression inhibits MDA-MB-231 breast cancer cell metastasis[J].Cancer Res,2005,65(16):7370-7377. 36 Podgorski I,Linebaugh BE,Koblinski JE,et al.Bone marrow-derived cathepsin K cleaves SPARC in bone metastasis[J].Am J Pathol,2009,175(3):1255-1269. |